Ausgabe 6/2024
Inhalt (16 Artikel)
Modernizing Newborn Screening in the Genomic Era: Importance of Health-Related Quality of Life
- Open Access
- Commentary
Ellen Kim DeLuca, Ann Chen Wu, Kurt D. Christensen, Davene R. Wright, Jennifer Yeh, Hadley Stevens Smith
A Systematic Review of the Impact of Spinal Cord Injury on Costs and Health-Related Quality of Life
- Open Access
- Systematic Review
Modou Diop, David Epstein
Cost-Effectiveness of Dupilumab and Oral Janus Kinase Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis in Singapore
- Open Access
- Original Research Article
Clarence Ong, Jamaica Briones, Zhi Zhen Lim, Nisha Suyien Chandran, Haur Yueh Lee, Benny Kaihui Li, Yik Weng Yew, Hwee-Lin Wee
Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses
- Open Access
- Original Research Article
Fatemeh Mirzayeh Fashami, Jean-Eric Tarride, Behnam Sadeghirad, Kimia Hariri, Amirreza Peyrovinasab, Mitchell Levine
Economic Impact of Bladder Cancer in the USA
- Open Access
- Original Research Article
Otavio Clark, Tulio Sarmento, Anthony Eccleston, Julia Brinkmann, Renato Picoli, Vamsi Daliparthi, Jorine Voss, Sanjana Chandrasekar, Allison Thompson, Jane Chang
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
- Open Access
- Original Research Article
Matilde Slot, Thomas Bøjer Rasmussen, Mette Nørgaard, Carsten Schade Larsen, Lars Holger Ehlers
Clinicians’ Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment
- Open Access
- Original Research Article
Alexander Keenan, Chiara Whichello, Hoa H. Le, David M. Kern, Gabriela S. Fernandez, Vicky Turner, Anup Das, Matt Quaife, Amy Perrin Ross
Estimation of the Clinical, Economic, and Social Burden of Stage IV Non-Small Cell Lung Cancer in Mexico
- Open Access
- Original Research Article
Denisse Añorve Bailon, Javier Picó-Guzmán, Sergio Cifuentes, Rogelio Trejo, Jeronimo Rodríguez Cid, Juan Jose Juarez-Vignon Whaley, Alan Alexis Heredia Zepeda, Raquel Gerson, Christian Patricio Camacho-Limas, José Fabián Martínez-Herrera, Diana Bonilla Molina, Efraín Camarín Sánchez, Daniela Shveid Gerson
Cost-Utility Analysis of Adjuvant Olaparib for Germline BRCA1/2-Mutated, High-Risk HER2-Negative Early Breast Cancer in Spain
- Open Access
- Original Research Article
Sergio Cedillo, Almudena González-Domínguez, Yoana Ivanova-Markova, Rafael López López, Sara López-Tarruella Cobo, José Alberto Peña Pedrosa
Comparison of Two Financial Incentives to Encourage the Use of Adalimumab Biosimilars: Results of a French Experiment Close to Clinicians
- Open Access
- Original Research Article
Marion Tano, Pascal Paubel, Matthieu Ribault, Albane Degrassat-Théas
Estimating Australian Population Utilities for Inherited Retinal Disease Using Time Trade-Off
- Open Access
- Original Research Article
Maria Farris, Stephen Goodall, Richard De Abreu Lourenco, Brendan Mulhern, Kathleen Manipis, Elena Meshcheriakova, Milena Lewandowska
Modelling Adverse Events in Patients Receiving Chronic Oral Corticosteroids in the UK
- Open Access
- Original Research Article
Danny Gibson, Neil Branscombe, Neil Martin, Andrew Menzies-Gow, Priya Jain, Katherine Padgett, Florian Yeates
The Economic Impact of Introducing RefluxStop for Refractory Gastroesophageal Reflux Disease on the Italian Healthcare System
- Open Access
- Original Research Article
Sam Harper, Muralikrishnan Kartha, Stuart Mealing, Maurizio Pavanello, Luigi Bonavina
Artificial-Intelligence Cloud-Based Platform to Support Shared Decision-Making in the Locoregional Treatment of Breast Cancer: Protocol for a Multidimensional Evaluation Embedded in the CINDERELLA Clinical Trial
- Open Access
- Protocol
Ludovica Borsoi, Elisabetta Listorti, Oriana Ciani
Correction: Cost-Effectiveness of Dupilumab and Oral Janus Kinase Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis in Singapore
- Open Access
- Correction
Clarence Ong, Jamaica Briones, Zhi Zhen Lim, Nisha Suyien Chandran, Haur Yueh Lee, Benny Kaihui Li, Yik Weng Yew, Hwee-Lin Wee
Publisher Correction: Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison Between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses
- Open Access
- Publisher Correction
Fatemeh Mirzayeh Fashami, Jean-Eric Tarride, Behnam Sadeghirad, Kimia Hariri, Amirreza Peyrovinasab, Mitchell Levine
